LncRNA LINC00680 Acts as a Competing Endogenous RNA and Is Associated With the Severity of Myasthennia Gravis

LncRNA LINC00680 Acts as a Competing Endogenous RNA and Is Associated With the Severity of Myasthennia Gravis

Background and PurposeMyasthenia gravis (MG) is a T cell-dependent antibody-mediated autoimmune disorder that can seriously affect patients' quality of life. However, few studies have focused on the severity of MG. Moreover, existing therapeutic efforts, including those targeting biomarkers for...

Full description

Bibliographic Details
Main Authors: Li Liu, Huixue Zhang, Xiaoyu Lu, Lifang Li, Tianfeng Wang, Shuang Li, Xu Wang, Si Xu, Lei Li, Qian Li, Tingting Yi, Tao Wu, Zhimin Chen, Hongyu Gao, Jianjian Wang, Lihua Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Neurology
Subjects:
LINC00680
severity
myasthenia gravis
competing endogenous RNA (ceRNA)
biomarker
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.833062/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2022.833062/full

Similar Items